PW03-029 – Risk factors for AA-type amyloidosis in Germany
نویسندگان
چکیده
Methods Seventy-three patients with FMF and 39 patients with active systemic inflammation due to autoimmune or idiopathic inflammation were evaluated in our reference center for amyloidosis. Mutations in MEFV and the SAA-1 exon 3 variants were analyzed for their contribution to AA risk. Amyloidosis was detected in all cases by congo red staining of kidney or bowel biopsy specimens and AA was classified by immunohistochemistry.
منابع مشابه
Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis.
OBJECTIVE To clarify the clinical significance of the SAA1.3 allele in the development and outcome of AA amyloidosis in Japanese patients with rheumatoid arthritis (RA). METHODS One hundred and twenty RA patients (60 alive and 60 dead) fulfilling the 1987 ACR criteria and 62 RA patients with biopsy-confirmed amyloid A (AA) amyloidosis (36 alive and 26 dead) were enrolled. The SAA1 genotypes w...
متن کاملExperimental transmission of systemic AA amyloidosis in autoimmune disease and type 2 diabetes mellitus model mice
AA amyloidosis is a protein misfolding disease characterized by extracellular deposition of amyloid A (AA) fibrils. AA amyloidosis has been identified in food animals, and it has been postulated that AA amyloidosis may be transmissible to different animal species. Since the precursor protein of AA fibrils is serum amyloid A (SAA), which is an inflammatory acute phase protein, AA amyloidosis is ...
متن کاملGastric but not Renal Amyloid Deposition is Removed by Biologics Therapy in AA Amyloidosis Patients with Rheumatoid Arthritis
Objectives: Several biologics therapy reportedly regress gastric amyloid deposition in AA amyloidosis patients, but it is uncertain whether they can also regress renal amyloid deposition. We carried out serial renal biopsy to clarify the regression of amyloid deposition in kidney by biologics. Methods: After the diagnosis of AA amyloidosis was determined by gastric biopsy to rheumatoid arthriti...
متن کاملEffectiveness of etanercept vs cyclophosphamide as treatment for patients with amyloid A amyloidosis secondary to rheumatoid arthritis.
OBJECTIVES To compare the effectiveness of an alkylating agent with that of a biologic agent in the treatment of patients with amyloid A (AA) amyloidosis secondary to RA and to assess the association of the serum AA (SAA) 1.3 allele with treatment. METHODS CYC and etanercept (ETN) were administered to 62 and 24 RA patients, respectively, who were confirmed with biopsy as having AA amyloidosis...
متن کاملP02-019 - Detection of risk factors for AA-amyloidosis
Introduction Systemic reactive (AA) amyloidosis represents the most important complication within TNF receptor associated periodic syndrome (TRAPS), familial Mediterranean fever (FMF) and other autoinflammatory syndromes, progressively leading to endstage renal failure. The homozygous condition of the serum amyloid A (SAA) variant SAA1.1 is significantly associated with the occurrence of AA amy...
متن کامل